| Stage | DHI | % of rev | ECG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.2B | 100.00% | $1.2B | 100.00% | DHI ×7.49 |
| Gross profit | $2.1B | 23.26% | $183M | 14.85% | DHI +8.4pp |
| Operating income | $1.2B | 12.52% | $112M | 9.08% | DHI +3.4pp |
| Pre-tax income | $1.2B | 13.29% | $110M | 8.93% | DHI +4.4pp |
| Net income | $919M | 9.96% | $84M | 6.81% | DHI +3.1pp |
| Stage | DHI | ECG | Gap · A − B |
|---|---|---|---|
| Revenue | $9.2B100.00% | $1.2B100.00% | DHI ×7.49 |
| Gross profit | 23.26%$2.1B | 14.85%$183M | DHI +8.4pp |
| Operating income | 12.52%$1.2B | 9.08%$112M | DHI +3.4pp |
| Pre-tax income | 13.29%$1.2B | 8.93%$110M | DHI +4.4pp |
| Net income |
| 9.96%$919M |
| 6.81%$84M |
| DHI +3.1pp |
No shared counterparties.